Phase I Study in Advanced Cancer Patients of a Diversified Prime-and-Boost Vaccination Protocol Using Recombinant Vaccinia Virus and Recombinant Nonreplicating Avipox Virus to Elicit Anti–Carcinoembryonic Antigen Immune Responses
John L. Marshall(Vince Lombardi Cancer Clinic), Jeffrey Schlom(National Cancer Institute), Mary Ann Toomey(Georgetown University), Kristen Faraguna(Georgetown University), Ellen Richmond(Georgetown University), Philip M. Arlen(Dana-Farber Cancer Institute), Kwong Y. Tsang(Center for Biologics Evaluation and Research), Edmund A. Gehan(Georgetown University), Ronald A. Peck(Georgetown University), Ping Chang(Georgetown University), Robert J. Hoyer(Georgetown University), James E. Pedicano(Georgetown University)
Cited by 357
Related Papers
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
|Journal of neurosurgery|1978|1.7k
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
|Nature|2011|1.3k